1,425 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Nivagen Pharmaceuticals recalled 13,536 containers of zinc oxide ointment on October 31, 2025. The recall follows deviations from current Good Manufacturing Practices (cGMP). Consumers must stop using the product immediately and contact healthcare providers for guidance.
Dynarex Corporation recalled 2,592 bottles of WeCare Zinc Oxide Ointment on October 31, 2025, due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers and healthcare providers must stop using the ointment immediately and seek guidance.
Dynarex Corporation recalled 8,184 bottles of Dynagel Moisturizing Wound Hydrogel on October 31, 2025. The recall follows deviations from current Good Manufacturing Practices (cGMP). Consumers should stop using the product immediately and consult healthcare providers for guidance.
Dyrnarex Corporation recalled 1,560 containers of Dynashield Skin Protectant on October 31, 2025. The product may not meet current Good Manufacturing Practice standards. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Aizu Olympus recalled 6,578 OER-Elite medical devices following safety concerns. The recall, announced on October 31, 2025, urges patients and healthcare providers to stop using the device immediately. Repairs should only be conducted by trained personnel to ensure safety.
Philips North America recalled 1,913,441 IntelliVue Patient Monitors on October 31, 2025. The monitors may fail to alarm, posing a serious risk to patient safety. Healthcare providers and patients should stop using the device immediately and follow recall instructions.
Dynarex Corporation recalled 2,400 containers of Wecare Calasoothe on October 31, 2025, due to cGMP deviations. The recall affects the 4 oz ointment, as it may not meet safety standards. Consumers should stop using the product immediately and consult their healthcare providers.
Nivagen Pharmaceuticals recalled 7,920 bottles of Zinc Oxide Ointment on October 31, 2025. The recall follows cGMP deviations that could impact product safety. Consumers should cease use immediately and consult healthcare providers for advice.
Philips recalled 1,913,441 IntelliVue MP40 monitors on October 31, 2025, due to a failure to alarm. This defect poses a high risk to patient safety. The recall affects devices distributed worldwide, including in the US.
cGMP deviations
Philips North America recalled 1,913,441 IntelliVue MP5 monitors on October 31, 2025, due to a failure to alarm. The recall affects devices distributed worldwide, including the United States. Patients and healthcare providers must stop using the monitors immediately.
Philips North America recalled 1,913,441 IntelliVue Patient Monitors on October 31, 2025. A potential issue causes the monitors to fail to alarm, posing serious risks to patient safety. Consumers and healthcare providers should stop using these devices immediately and follow recall instructions.
Cipla USA recalled 4,438 cartons of Phytonadione Injectable Emulsion on October 31, 2025. The product failed stability specifications, raising concerns about its safety. Consumers and healthcare providers must stop using the product immediately and seek guidance.
Trifecta Pharmaceuticals USA recalled 12,150 bottles of Globe Clotrimazole Cream on October 31, 2025. The recall stems from deviations in current Good Manufacturing Practices (cGMP). Consumers should stop using the cream immediately and contact their healthcare providers.
Blossom Pharmaceuticals recalled 9,600 containers of Lanashield Skin Barrier on October 31, 2025 due to cGMP deviations. Consumers and healthcare providers should stop using the product immediately. The recall affects products distributed nationwide in the USA.
Stryker Corporation recalled 39,148 BrainPath devices on October 31, 2025, due to a latex allergy risk. The tape used to secure components contains latex, despite being labeled latex-free. This recall affects devices distributed worldwide, including the U.S. and multiple countries.
Stryker recalled 39,148 NICO Myriad Handpieces on October 31, 2025, due to a latex hazard. The packaging tape contains latex despite products being labeled latex-free. This poses a significant allergy risk to patients and healthcare providers.
Philips North America recalled 1,913,441 IntelliVue MP60 monitors on October 31, 2025. The monitors may fail to alarm, posing a significant risk to patient safety. Affected devices were distributed worldwide, including the United States and multiple countries.
Philips North America recalled 1,913,441 IntelliVue MP80 monitors on October 31, 2025. The devices may fail to alarm, presenting a high risk to patient safety. Healthcare providers and patients should stop using the monitors immediately.
Stryker recalled 289 Arise 1000EX mattresses on October 31, 2025. The recall affects products sold nationwide due to potential incompatibility with MV3 beds. Users should stop using these mattresses immediately.
Olympus Corporation of the Americas recalled 7,803 units of the HX-400U-30 ligating device on October 30, 2025. The device may fail to release as intended, posing significant risks to patients. Healthcare providers must stop using the device immediately and follow recall instructions.
B Braun Medical recalled 960 IV administration sets on October 29, 2025. The recall affects sets used with Infusomat Space, Outlook, and Vista pumps. Users face a high risk of medication backflow and occlusion.
B Braun Medical recalled 187,464 IV administration sets on October 29, 2025. The recall stems from the potential for medication backflow and occlusion. The affected products were distributed worldwide, including the U.S. and Canada.
B Braun Medical recalled 45,288 IV administration sets on October 29, 2025. The recall addresses a risk of backflow from secondary IV containers into primary containers. Users must stop using the product immediately and follow manufacturer instructions.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.